ADTX

Aditxt, Inc.

Insider Trades

NameValueActionPriceCurrent Price
Takeover Time 2026 LLC10 Percent Owner
$68k3.4M shares
SellJun 23, 2026
$0.02
$0.01
DRW Securities, LLC10 Percent Owner
$1.0k126.8k shares
SellJun 17, 2026
$0.0079
$0.01
Gong Sandie10 Percent Owner
$6.9k100k shares
SellJun 9, 2026
$0.0688
$0.0185
Hrt Financial LP10 Percent Owner
$46k735.5k shares
SellJun 5, 2026
$0.062
$0.0185
Hrt Financial LP10 Percent Owner
$64k843.6k shares
BuyJun 4, 2026
$0.076
$0.0185

News

businesswire.comAditxt Signed Definitive Agreement Valuing Ignite Proteomics at Approximately $150 Millionbusinesswire.comJun 9businesswire.comIgnite Proteomics Announces Prospective 10,000-Patient Oncology Registry to Evaluate Functional Proteomics in Cancer Therapy Selectionbusinesswire.comJun 8businesswire.comAditxt, Inc. Appoints Jeffrey M. Busch as Interim Chief Executive Officer; Founder and Former CEO of $1B NYSE Enterprise Which Delivered ~8.5% Dividends to Shareholdersbusinesswire.comJun 1businesswire.comAditxt, Inc. (NASDAQ: ADTX) Announces 1-for-27 Reverse Stock Split Effective at the Open of Trading on May 18, 2026businesswire.comMay 14businesswire.comDana-Farber Cancer Institute Study Demonstrates Predictive Value of Ignite Proteomics' RPPA Platform for T-DXd (Enhertu®) Therapy in Metastatic Breast Cancer Patientsbusinesswire.comApr 20